Detalhe da pesquisa
1.
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights.
Bioorg Med Chem Lett
; 21(14): 4228-32, 2011 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684157
2.
Inhibition of inducible nitric oxide synthase in respiratory diseases.
Biochem Soc Trans
; 37(Pt 4): 886-91, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19614613
3.
The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Mol Pharmacol
; 69(1): 328-37, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16223957
4.
In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase.
J Pharmacol Exp Ther
; 317(1): 181-7, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16368897
5.
Structure and potential C-terminal dimerization of a recombinant mutant of surfactant-associated protein C in chloroform/methanol.
Eur J Biochem
; 271(11): 2076-85, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15153097
6.
Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
Mol Pharmacol
; 61(6): 1366-76, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12021398